Home » Topics » Medical devices and technologies » Diagnostics

Diagnostics
RSS

Vermillion receives CE mark for OVA1 test for ovarian cancer detection

Sep. 23, 2010

Janssen Pharmaceutica claims new phosphodiesterase 10A ligands

Sep. 20, 2010

Number of U.K. sites for international OvPlex study increases

Sep. 15, 2010

Technetium-99m-labeled MIP-1340 shows suitability for prostate cancer imaging

Sep. 8, 2010

OvPlex ovarian cancer diagnostic is launched in Singapore

Sep. 7, 2010

PET ligand [11C]-AZ-10419369 is sensitive to changes in brain serotonin levels in vivo

Sep. 7, 2010

U.S. scientists identify new cromolyn derivatives

Aug. 20, 2010

U.S. scientists describe new magnetic nanoparticles for multimodal imaging

Aug. 17, 2010

Midbrain [18F]-fallypride PET can reveal impulsivity in individuals

Aug. 12, 2010

Mallinckrodt discovers new diagnostics for renal disorders

Aug. 9, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...